A clinical trial to rule out pulmonary embolism showed that P3T Cardiac provided greater contrast enhancement of the pulmonary arteries, resulting in a higher percentage of diagnostic exams to rule out pulmonary embolism when compared to standard injection protocols.

Each new P3T application we release furthers our commitment to outcome-based innovation, and enables more patients to receive the benefits personalized imaging delivers.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.